clinical trial · NCT00408330
A Study of Azelaic Acid (AzA) 15% Gel in the Treatment of Seborrheic Dermatitis of the Face
LEO Pharma·phase2·completed·n = 48
Seborrheic Dermatitis on the FaceAzelaic Acid 15% GelInactive 15% gel base
brief summary
This study is to determine whether a medication on the market for other indications is effective and safe in treating seborrheic dermatitis of the face.
started
Dec 1, 2006
primary completion
Mar 1, 2007
completion
Mar 1, 2007
last updated
Jun 9, 2023
detailed description
To test the efficacy and safety of azelaic acid 15% gel in the treatment of seborrheic dermatitis of the face
official title
A Double-Blind, Randomized, Vehicle-Controlled, Six-Week Exploratory Multicenter Pilot Study of the Efficacy and Safety of Azelaic Acid (AzA) 15% Gel in the Topical Treatment of Mild to Moderate Seborrheic Dermatitis of the Face
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol